Skip to main content
High RiskFDAfda-F-0032-2020UNDECLARED ALLERGEN

Gridestone Cafe Swiss Style Cocoa Mix, Net Wt. 32 OZ (2 lb) 907 g, Distributed by Performance Food Group, Richmond, VA packaged 12 boxes ...

Category
Units Affected
1,162
Recall Date
August 30, 2019
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0032-2020.

Products were made with a cocoa powder that contained soy lecithin but soy was not declared on the label.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0032-2020.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Diamond Crystal Brands Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0032-2020.

Diamond Crystal Brands Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Diamond Crystal Brands Inc Recall FAQ

Diamond Crystal Brands Inc is the subject of a food safety report: Gridestone Cafe Swiss Style Cocoa Mix, Net Wt. 32 OZ (2 lb) 907 g, Distributed by Performance Food Group, Richmond, VA packaged 12 boxes .... The notice was published on August 30, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 1,162 units are potentially affected.